Cutaneous Microvascular Occlusion Syndrome As the First Manifestation of Catastrophic Lupus-Associated Antiphospholipid Antibody Syndrome: A Case Report Publisher Pubmed



Hosseini NS¹ ; Babaei S² ; Rahimi H³ ; Gheissari A⁴ ; Sedaghat B⁵ ; Pourmahdiboroujeni M⁶ ; Abtahinaeini B⁷
Source: Journal of Medical Case Reports Published:2023

Abstract

Background: Antiphospholipid syndrome (APS), defined by thrombotic events or obstetric complications in the presence of persistently high antiphospholipid antibodies, is characterized by a wide variety of clinical presentations and the effects of vascular occlusion can impact almost any organ system or tissue. Since adult-onset APS classification criteria are not well verified in pediatrics (where pregnancy-related problems are rare), estimating childhood prevalence is challenging. Stroke and pulmonary embolism are thromboembolic events occurring in children that can cause considerable long-term morbidity. Children with APS are more prone to recurrent thromboembolism than adults. Cutaneous symptoms are prominent and typically represent the first clue of APS. Although dermatologic findings are exceedingly heterogeneous, it is essential to consider which dermatological symptoms justify the investigation of antiphospholipid syndrome and the required further management. Case presentation: We describe a seven-year-old Iranian boy with retiform purpura and acral cutaneous ischemic lesions as the first clinical presentation of antiphospholipid syndrome in the setting of systemic lupus erythematous. Conclusion: APS in pediatrics, is associated with a variety of neurologic, dermatologic, and hematologic symptoms. Therefore, it is essential for pediatricians to be aware of the rare appearance of Catastrophic APS as an initial indication of APS. © 2023, BioMed Central Ltd., part of Springer Nature.